GABRIEL CERRONE Insider Trading
Get free email notifications about insider trading for GABRIEL CERRONE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GABRIEL CERRONE. GABRIEL CERRONE is a Chairman in CALLISTO PHARMACEUTICALS INC ($KAL) and a Director in CALLISTO PHARMACEUTICALS INC ($KAL).
Address: C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVE., SUITE 1609 NEW YORK 10170 NY
Companies in which GABRIEL CERRONE is an Insider
CALLISTO PHARMACEUTICALS INC
Trading Symbol: KALIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GABRIEL CERRONE: Chairman, Director
Holdings: 2,126,737 shares
Latest Transaction: Jan 27 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GABRIEL CERRONE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2010 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Option Exercise | A | 0.26 | 390,000 | 101,400 | 1,698,055 | |
Jan 26 2007 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Option Exercise | A | 0.96 | 225,000 | 216,000 | 1,525,000 | |
Nov 27 2006 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Option Exercise | P | 0.75 | 30,000 | 22,500 | 30,000 | |
Nov 27 2006 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Option Exercise | P | 0.75 | 2,250 | 1,688 | 2,250 | |
Jun 13 2005 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Buy | P | 1.00 | 5,000 | 5,000 | 2,126,737 | 2.1 M to 2.1 M (+0.24 %) |
Jun 01 2005 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Buy | P | 1.00 | 8,000 | 7,976 | 2,121,737 | 2.1 M to 2.1 M (+0.38 %) |
May 23 2005 | KAL | CALLISTO PHARMACEU ... | CERRONE GABRIEL | Chairman | Buy | P | 1.02 | 12,500 | 12,750 | 2,113,737 | 2.1 M to 2.1 M (+0.59 %) |